Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Emeryville, CA
SEC filing record 1 source field available
Fiscal year end
31 December
4D Molecular Therapeutics, Inc. has filed 421 SEC EDGAR filings since 13 Aug 2015

SEC filing history

Showing 401-421 of 421 matching filings.

Per page
25
Current page
17
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
10 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-39782

CERT filing

Filing date
10 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-250150

S-1/A

Filing date
10 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-39782

8-A12B

Filing date
08 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-250150

S-1/A

Filing date
07 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
04 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
02 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-250150

S-1

Filing date
17 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-03669

DRS filing

Filing date
14 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-234021

RW

Filing date
21 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-234021

S-1

Filing date
30 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-02769

DRS/A filing

Filing date
30 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-02769

DRS filing

Filing date
02 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-321085

D filing

Filing date
11 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-249653

D filing

Filing date
19 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-245752

D filing

Filing date
13 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .